Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
0.8501
-0.0564 (-6.22%)
Apr 2, 2026, 9:31 AM EDT - Market open
ZYBT Employees
Zhengye Biotechnology Holding had 277 employees as of December 31, 2024. The number of employees decreased by 9 or -3.15% compared to the previous year.
Employees
277
Change (1Y)
-9
Growth (1Y)
-3.15%
Revenue / Employee
$77,473
Profits / Employee
-$9,760
Market Cap
40.29M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 277 | -9 | -3.15% |
| Dec 31, 2023 | 286 | -8 | -2.72% |
| Dec 31, 2022 | 294 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| InterCure | 320 |
| Rockwell Medical | 244 |
| Cumberland Pharmaceuticals | 93 |
| Aytu BioPharma | 83 |
| BioXcel Therapeutics | 37 |
| SCYNEXIS | 18 |
| Talphera | 13 |
| Incannex Healthcare | 12 |
ZYBT News
- 7 weeks ago - Zhengye Biotechnology Holding Limited Issues 2026 Chairman's Letter to Shareholders - GlobeNewsWire
- 9 months ago - Zhengye Biotechnology Holding Limited Announces Fiscal Year 2024 Financial Results - PRNewsWire
- 11 months ago - Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-F - GlobeNewsWire
- 1 year ago - Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters' Over-Allotment Option - GlobeNewsWire
- 1 year ago - Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering - GlobeNewsWire
- 1 year ago - Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering - GlobeNewsWire